NKIRUKA ARENE: Open Payments
NPI 1477517332 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 37 payments from 9 companies in 2025. Trend: 2023 $227 · 2024 $637 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $337 |
| Collegium Pharmaceutical, Inc. | 5 | $111 |
| Medtronic, Inc. | 1 | $79 |
| Indivior Inc. | 2 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Braeburn Inc. | 2 | $47 |
| Tonix Medicines, Inc. | 1 | $25 |
| Valinor Pharma, LLC | 1 | $19 |
| Orexo US, Inc. | 1 | $18 |
Products named: BOTOX, Belbuca, SYNCHROMEDII, SUBLOCADE, INGREZZA, BRIXADI, TONMYA, QULIPTA.
Industry payments across MD — which companies pay providers there.
